CV Lattes
ResearcherID
ORCID
Secretaria da Saúde (São Paulo - Estado). Instituto Butantan (Institutional affiliation from the last research proposal) Birthplace: Brazil
Graduate in Biological Sciences at Universidade de São Paulo (1992), and ph.d. in Genetics at Universidade de São Paulo (1997). Has experience in vaccine development, acting on the following subjects: Streptococcus pneumoniae and adjuvants. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Streptococcus pneumoniae causes several diseases, such as otitis media, sinusitis, pneumonia, sepsis and meningitis. Polysaccharide conjugate vaccines led to a significant reduction in invasive pneumococcal disease caused by serotypes included in the vaccine formulations, but serotype replacement by non-vaccine serotypes was observed. Moreover, after a period with reduction of pneumococca…
Streptococcus pneumoniae causes several diseases such as otitis media, sinusitis, pneumonia, sepsis and meningitis. The polysaccharide conjugate vaccines led to reduction of pneumococcal invasive disease caused by serotypes included in the vaccine formulation, but substitution by non-vaccine serotypes was observed. New vaccine formulations are thus necessary to control pneumococcal diseas…
Streptococcus pneumoniae is an important human pathogen, causing diseases such as otitis media, sinusitis, pneumonia, bacteremia and meningitis. The polysaccharide conjugate vaccines are based on the induction of antibodies against the capsular polysaccharide and are very efficient in preventing invasive disease in children. Substitution by non-vaccine serotypes in colonization of the nas…
Streptococcus pneumoniae is an important human pathogen, causing diseases such as otitis media, sinusitis, pneumonia, bacteremia and meningitis. Polysaccharide conjugate vaccines (PCV) are based on the induction of antibodies against capsular polysaccharides and they are very efficient against invasive pneumococcal infections. The widespread use of PCVs has also led to an increase in colo…
(Only some records are available in English at this moment)
Infections caused by Streptococcus pneumoniae remain a major public health burden despite the use of polysaccharide conjugate vaccines (PCVs). PCVs led to an impressive reduction in invasive pneumococcal disease (pneumonia with bacteremia, bacteremia, meningitis) caused by serotypes included in the vaccine formulations. An increase both in colonization and invasive disease caused by non-v…
Streptococcus pneumoniae, or pneumococcus, is a component of the human microbiota, but in some cases it can cause diseases such as Sinusitis, Otitis Media, Pneumonia, Sepsis and Meningitis. Vaccination is the most effective strategy to control pneumococcal infections. The first generation pneumococcal vaccines are composed by free capsular polysaccharides (PS), inducing temporary protecti…
Streptococcus pneumoniae is an important human pathogen, causing severe diseases such as pneumonia, bacteremia, sepsis and meningitis. The currently available vaccines are based on the response against the capsular polysaccharide, but they have some shortcomings such as high cost and restricted serotype coverage. The development of new vaccines against pneumococcal infections thus remains…
(Only some records are available in English at this moment)
Streptococcus pneumoniae, or pneumococcus, is a component of human microbiota, but in some cases it can cause serious diseases. Vaccines are the most important way to control pneumococcal infections and there are currently two licensed vaccines based on capsular polysaccharides (PS). The pneumococcal conjugate vaccines (PCVs) led to an impressive decrease in the cases of invasive pneumoco…
| 1 / 1 | Ongoing grants |
| 13 / 11 | Completed research grants |
| 13 / 8 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 28 / 21 | All research grants and scholarships |
| Associated processes | |